subject: CHEBI:41879

object_name: systemic inflammatory response syndrome


subject: UNII:QY8BWX1LJ5

subject_name: Taladegib

object_name: Adult Rhabdomyosarcoma

tested_intervention: yes


subject: UNII:QY8BWX1LJ5

object_name: rhabdomyosarcoma


subject: UNII:QY8BWX1LJ5

object_name: Childhood Rhabdomyosarcoma


subject: UNII:QY8BWX1LJ5

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:QY8BWX1LJ5

object_name: childhood medulloblastoma


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: cerebral infarction


subject: CHEBI:45716

subject_name: Vorinostat

object_name: liver cancer

tested_intervention: unsure


subject: CHEBI:45716

object_name: liver neoplasm


subject: CHEBI:45716

object_name: Adult Liver Carcinoma


subject: CHEBI:45716

object_name: liver carcinoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: meniscus; disorder


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:49575

subject_name: Diazepam


subject: CHEBI:49575

object_name: opioid use


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:6129

subject_name: Ketorolac


subject: UMLS:C0731141

subject_name: GTN

object_name: Angina pectoris


subject: CHEBI:91437

object_name: myeloid leukemia


subject: UMLS:C5204520

object_name: Classical Hodgkin lymphoma refractory


subject: UMLS:C5204520

object_name: Relapsing classical Hodgkin lymphoma


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: UMLS:C4086994


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Extrapulmonary Small Cell Carcinoma


subject: CHEBI:131166

object_name: Small cell lung cancer recurrent


subject: CHEBI:131166

object_name: Small cell lung cancer limited stage


subject: CHEBI:131166

object_name: Small cell lung cancer extensive stage


subject: CHEBI:131166

object_name: Platinum-Sensitive Lung Small Cell Carcinoma


subject: CHEBI:131166

object_name: Platinum-Resistant Lung Small Cell Carcinoma


subject: UMLS:C3179434

subject_name: Brilique

object_name: acute coronary syndrome


subject: UMLS:C3179434

object_name: cardiovascular disorder


subject: UMLS:C0916588

subject_name: rusalatide acetate

object_name: radius fracture


subject: UMLS:C1608705

subject_name: Chrysalin


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Nutritional status


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:18772499

object_name: alcohol dependence


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UMLS:C5690696

subject_name: MitoQ

object_name: type 2 diabetes mellitus


subject: UMLS:C5690696

object_name: Insulin resistance


subject: UNII:2AD53WQ2CX

object_name: chronic obstructive pulmonary disease


subject: CHEBI:8364

subject_name: Prazosin

object_name: Headache


subject: CHEBI:8364

object_name: Headache, CTCAE


subject: CHEBI:8364

object_name: concussion


subject: CHEBI:8364

object_name: Mild Traumatic Brain Injury


subject: CHEBI:8364

object_name: traumatic encephalopathy


subject: UMLS:C1815270

subject_name: Biostate

object_name: hereditary von Willebrand disease


subject: UMLS:C1815270

object_name: von Willebrand disease (hereditary or acquired)


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: UMLS:C1831904

subject_name: ThermoDox

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831904

object_name: breast carcinoma


subject: UMLS:C1831904

object_name: breast cancer


subject: CHEBI:94691

object_name: myocardial infarction


subject: CHEBI:94691

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:94691

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:80630

subject_name: Irinotecan

object_name: peritoneal carcinomatosis


subject: CHEBI:80630

object_name: appendix cancer


subject: CHEBI:80630

object_name: appendix carcinoma


subject: UMLS:C2729285

subject_name: Injection, degarelix, 1 mg administered

object_name: invasive ductal breast carcinoma


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: CHEBI:94705

object_name: tinea pedis


subject: CHEBI:9448

subject_name: Terbinafine


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium

object_name: type 2 diabetes mellitus


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:50885

subject_name: Fludrocortisone

object_name: sensorineural hearing loss disorder


subject: UNII:UYB6UOF69L

subject_name: Maralixibat

object_name: Cholestatic liver disease


subject: UNII:UYB6UOF69L

object_name: progressive familial intrahepatic cholestasis type 1


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Parkinson disease


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:391960

subject_name: Darifenacin


subject: CHEBI:42797

subject_name: Gabapentin

object_name: chronic pain due to trauma


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: lung cancer


subject: UMLS:C5444737

object_name: lung neoplasm


subject: UMLS:C5444737

object_name: lung carcinoma


subject: UMLS:C5444737

object_name: Radiation Sickness


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Mild intermittent asthma


subject: UMLS:C1951572

subject_name: Flovent Diskus


subject: UMLS:C4548849

object_name: Maternity blues


subject: CHEBI:16646

subject_name: carbohydrate

object_name: body weight


subject: CHEBI:36080

subject_name: protein


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: PUBCHEM.COMPOUND:71455937

object_name: cystic fibrosis


subject: CHEMBL.COMPOUND:CHEMBL4297744


subject: CHEBI:6931

subject_name: Midazolam

object_name: urinary tract infection


subject: CHEBI:6931

object_name: Recurrent urinary tract infections


subject: CHEBI:5441

subject_name: Glyburide

object_name: subarachnoid hemorrhage


subject: CHEBI:33376

subject_name: terbium atom

object_name: latent tuberculosis infection


subject: CHEBI:35020

subject_name: Tributyrin


subject: UMLS:C4331801

object_name: non-small cell lung carcinoma


subject: UMLS:C5854494

subject_name: Integrin AlphaVbeta3-targeted Small Molecule-drug Conjugate VIP236

object_name: neoplasm


subject: CHEBI:63115

subject_name: Fingolimod

object_name: breast carcinoma


subject: CHEBI:31215

subject_name: anecortave

object_name: glaucoma


subject: CHEBI:31215

object_name: Glaucoma, CTCAE


subject: CHEBI:31215

object_name: posterior uveitis


subject: CHEBI:32588

subject_name: Potassium chloride

object_name: hypokalemia


subject: CHEBI:32588

object_name: Chronic uremia


subject: CHEBI:32588

object_name: Hyperkalemia, CTCAE


subject: CHEBI:32588

object_name: Hyperkalemia


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: hypertension


subject: PUBCHEM.COMPOUND:157010100

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:157010100


subject: PUBCHEM.COMPOUND:157010100


subject: PUBCHEM.COMPOUND:157010100


subject: PUBCHEM.COMPOUND:157010100


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: lung adenocarcinoma


subject: UNII:KXG2PJ551I

object_name: cervical adenocarcinoma


subject: UNII:KXG2PJ551I

object_name: adenocarcinoma


subject: UNII:KXG2PJ551I

object_name: bile duct adenocarcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Type 2 diabetes mellitus in obese


subject: CHEBI:74705

object_name: morbid obesity


subject: CHEBI:74705

object_name: Class 3 Obesity


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C5575040

object_name: pancreatic neoplasm


subject: UMLS:C5575040

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5575040

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: cystitis


subject: PUBCHEM.COMPOUND:86217377

object_name: Cystitis, CTCAE


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: complete trisomy 21


subject: CHEBI:4696

object_name: Down syndrome


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: UMLS:C0733688

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:3267

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:3267

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:3267

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:6339

object_name: Dysmenorrhea


subject: DRUGBANK:DB11286

subject_name: Colloidal oatmeal

object_name: cardiovascular disorder


subject: DRUGBANK:DB11286

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB11286

object_name: obesity


subject: DRUGBANK:DB11286

object_name: Obesity, CTCAE


subject: CHEBI:4315

subject_name: Danazol

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:4315

object_name: aplastic anemia


subject: CHEBI:4315

object_name: idiopathic aplastic anemia


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Recurrent Brain Neoplasm


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Nerve Pain


subject: UMLS:C2983740

subject_name: Lipovaxin-MM

object_name: melanoma


subject: UMLS:C5554956

subject_name: Anti-GITR AgonisticMonoclonal Antibody REGN6569

object_name: head and neck squamous cell carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Recurrent Endometrial Cancer


subject: CHEBI:6129

subject_name: Ketorolac

object_name: urinary system disorder


subject: CHEBI:7852

subject_name: Oxycodone


subject: UNII:SZU399KT7Q

object_name: irritable bowel syndrome


subject: UNII:73H2I6QS54

subject_name: SACITUZUMAB

object_name: ovarian cancer


subject: UNII:73H2I6QS54

object_name: ovarian neoplasm


subject: UNII:73H2I6QS54

object_name: ovarian carcinoma


subject: UNII:73H2I6QS54

object_name: uterine cancer


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C4726721

subject_name: sacituzumab


subject: UMLS:C4726721


subject: UMLS:C4726721


subject: UMLS:C4726721


subject: CHEBI:36796

subject_name: duloxetine

object_name: Childhood Breast Carcinoma


subject: CHEBI:36796

object_name: breast carcinoma


subject: CHEBI:36796

object_name: breast cancer


subject: CHEBI:64816

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: acute lymphoblastic leukemia


subject: UNII:R30772KCU0

subject_name: Isatuximab


subject: UNII:R30772KCU0

object_name: acute myeloid leukemia


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:32660


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: CHEBI:30742


subject: PR:000012224

subject_name: glycodelin


subject: PR:000012224


subject: PR:000012224


subject: DRUGBANK:DB11360

subject_name: Lactobacillus plantarum

object_name: chronic kidney disease


subject: DRUGBANK:DB11360

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: epilepsy


subject: DRUGBANK:DB18078

object_name: focal segmental glomerulosclerosis


subject: DRUGBANK:DB18078

object_name: Alport syndrome


subject: UNII:69VKY8P7EA

object_name: childhood neoplasm


subject: UNII:69VKY8P7EA

object_name: neoplastic syndrome


subject: UNII:69VKY8P7EA

object_name: cancer or benign tumor


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C2004126


subject: UMLS:C2004126


subject: UNII:473BOU89F3

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4684450


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C0919079

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C0919079

object_name: Stage III Colorectal Cancer AJCC v8


subject: UMLS:C0919079

object_name: Advanced Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C0919079

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: PUBCHEM.COMPOUND:90199447

subject_name: TUVUSERTIB

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:DA9P7LN909

object_name: Childhood Breast Carcinoma


subject: UNII:DA9P7LN909

object_name: breast carcinoma


subject: UNII:DA9P7LN909

object_name: breast cancer


subject: UMLS:C5781322

subject_name: Insulin Like Growth Factor

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C5781322

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0037657

subject_name: Somatomedins


subject: UMLS:C0037657


subject: UMLS:C2985193

subject_name: Monofer

object_name: anemia


subject: UMLS:C2985193

object_name: Anemia, CTCAE


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UNII:7D0YB67S97

object_name: vitiligo


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: cancer


subject: DRUGBANK:DB17518

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17518

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17518

object_name: Solid Neoplasm


subject: DRUGBANK:DB17518

object_name: head and neck squamous cell carcinoma


subject: DRUGBANK:DB17518

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB17518

object_name: urothelial carcinoma


subject: DRUGBANK:DB17518

object_name: transitional cell carcinoma


subject: MESH:D002214

subject_name: Capsules

object_name: diabetic kidney disease


subject: MESH:D002214

object_name: chronic kidney disease


subject: MESH:D002214

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4050515

subject_name: Simo Decoction

object_name: colorectal cancer


subject: UMLS:C4050515

object_name: colorectal carcinoma


subject: UMLS:C4050515

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:18258

subject_name: Liothyronine

object_name: Compensated hypothyroidism


subject: PUBCHEM.COMPOUND:124389175


subject: CHEBI:81567

subject_name: Thyrotropin


subject: CHEBI:35940

subject_name: Protirelin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: liver disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Prediabetes


subject: UNII:1C6V77QF41

object_name: glucose intolerance


subject: UNII:1C6V77QF41

object_name: Impaired glucose tolerance


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa

object_name: hypogonadotropic hypogonadism


subject: UNII:T7K20Y2GWY

object_name: Klinefelter syndrome


subject: UMLS:C4719914

subject_name: Cysteamine Bitartrate Delayed-Release Capsules

object_name: cystinosis


subject: CHEBI:57761

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:57761

object_name: nephrolithiasis


subject: CHEBI:16410

subject_name: Pyridoxamine


subject: CHEBI:16410


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: coronary artery disorder


subject: UMLS:C1145201

object_name: coronary atherosclerosis


subject: UMLS:C1145201

object_name: rickets


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Langerhans cell histiocytosis specific to childhood


subject: UMLS:C0003442

object_name: Childhood Neuroblastoma


subject: UMLS:C0003442

object_name: neuroblastoma


subject: UMLS:C0003442

object_name: malignant soft tissue neoplasm


subject: UMLS:C0003442

object_name: sarcoma


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: heart failure


subject: CHEBI:71272

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UMLS:C0006280

subject_name: Bronchodilator Agents

object_name: emphysema


subject: UMLS:C0006280

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C0006280

object_name: COPD, severe early onset


subject: UMLS:C0006280

object_name: chronic obstructive pulmonary disease


subject: UNII:AJ212MS2O2

object_name: glucose metabolism disease


subject: UNII:AJ212MS2O2

object_name: diabetes mellitus


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Sinusitis, CTCAE


subject: CHEBI:5855

object_name: otorhinolaryngologic disease


subject: UMLS:C2703183

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C2703183

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UMLS:C2703183

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UMLS:C2703183

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: UMLS:C2703183

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C2703183

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: UMLS:C2703183

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UMLS:C2703183

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C2703183

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: UMLS:C2703183

object_name: Adult Acute Myelomonocytic Leukemia


subject: UMLS:C2703183

object_name: Adult Pure Erythroid Leukemia


subject: UMLS:C2703183

object_name: adult acute monocytic leukemia


subject: UMLS:C2703183

object_name: Adult Acute Monoblastic Leukemia


subject: UMLS:C2703183

object_name: Adult Erythroleukemia


subject: UMLS:C2703183

object_name: acute megakaryoblastic leukemia in adult


subject: GTOPDB:5962

subject_name: dovitinib

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:5962

object_name: clear cell renal carcinoma


subject: UNII:98OYR854NY

subject_name: Trabedersen

object_name: glioblastoma


subject: UNII:98OYR854NY

object_name: Childhood Glioblastoma


subject: UNII:98OYR854NY

object_name: adult glioblastoma


subject: UNII:98OYR854NY

object_name: Grade III Childhood Astrocytoma


subject: UNII:98OYR854NY

object_name: Adult Anaplastic Astrocytoma


subject: UNII:98OYR854NY

object_name: anaplastic astrocytoma


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: anorexia nervosa with significantly low body weight


subject: CHEBI:94534

subject_name: olanzapine


subject: UMLS:C1971564

subject_name: Injection, levetiracetam, 10 mg administered

object_name: Status epilepticus


subject: UMLS:C5203562

subject_name: Levetiracetam Liquid Injection


subject: CHEBI:182803

subject_name: Porfiromycine

object_name: Neck Carcinoma


subject: CHEBI:182803

object_name: head and neck cancer


subject: CHEBI:208611

subject_name: Porfiromycin


subject: CHEBI:208611


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Congenital postural scoliosis


subject: UMLS:C5203530

object_name: scoliosis


subject: UMLS:C5203530

object_name: Scoliosis, CTCAE


subject: UMLS:C5203530

object_name: Intraoperative Hemorrhage


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518


subject: CHEBI:4604

subject_name: dimenhydrinate

object_name: gastroenteritis


subject: UNII:7G4J1ZD9UQ

subject_name: VERNAKALANT HYDROCHLORIDE

object_name: atrial fibrillation


subject: UNII:7G4J1ZD9UQ

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:7G4J1ZD9UQ

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3528638

subject_name: vernakalant HCl


subject: UMLS:C3528638


subject: UMLS:C3528638


subject: UMLS:C1530479

subject_name: AMD 070

object_name: HIV infection


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: lumbar spinal stenosis


subject: UMLS:C2240391

object_name: spinal stenosis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:4466

object_name: mitochondrial disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UNII:E3AP71EM0O

subject_name: Fanapanel

object_name: Visual Acuity


subject: PR:000001026

subject_name: lymphocyte antigen 75

object_name: acute myeloid leukemia by FAB classification


subject: PR:000001026

object_name: acute myeloid leukemia


subject: PR:000001026

object_name: Myelodysplasia


subject: PR:000001026

object_name: Adult Myelodysplastic Syndrome


subject: PR:000001026

object_name: childhood myelodysplastic syndrome


subject: PR:000001026

object_name: Myelodysplastic Syndrome, CTCAE


subject: PR:000001026

object_name: High Risk Myelodysplastic Syndrome


subject: PR:000001026

object_name: juvenile myelomonocytic leukemia


subject: PR:000001026

object_name: chronic myelomonocytic leukemia


subject: PR:000001026

object_name: Blasts 30 Percent or Less of Bone Marrow Nucleated Cells


subject: PR:000001026

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: PR:000001026

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: Metastatic Renal Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: Metastatic Renal Cell Cancer


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: Ovarian clear cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: ovarian clear cell cancer


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: papillary renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: kidney neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297719

object_name: kidney cancer


subject: UMLS:C4329346


subject: UMLS:C4329346


subject: UMLS:C4329346


subject: UMLS:C4329346


subject: UMLS:C4329346


subject: UMLS:C4329346


subject: UMLS:C4329346


subject: CHEBI:133146

subject_name: Phe-Ala

object_name: acute lymphoblastic leukemia


subject: CHEBI:39002

subject_name: perfluoroadamantane


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:177298

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:177298

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:177298

object_name: sarcoma


subject: CHEBI:177298

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:177298

object_name: soft tissue sarcoma


subject: CHEBI:177298

object_name: uterine sarcoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:6942

subject_name: Minoxidil

object_name: ovarian cancer


subject: CHEBI:6942

object_name: ovarian neoplasm


subject: CHEBI:6942

object_name: ovarian carcinoma


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Low Back Pain, Mechanical


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:46195

subject_name: Acetaminophen


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab

object_name: myositis ossificans


subject: PUBCHEM.COMPOUND:56776542

object_name: fibrodysplasia ossificans progressiva


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UNII:571045EIM4


subject: UMLS:C3827124


subject: UMLS:C3827124


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Dyskinesia, Medication-Induced


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: head and neck squamous cell carcinoma


subject: UNII:L62556GPXB

subject_name: TEBOTELIMAB

object_name: Neck Carcinoma


subject: UNII:L62556GPXB

object_name: head and neck neoplasm


subject: UNII:L62556GPXB

object_name: head and neck cancer


subject: UNII:L62556GPXB


subject: CHEBI:230540

object_name: Advanced cancer


subject: UMLS:C2983789


subject: UMLS:C1541521

subject_name: AMG 386

object_name: Childhood Breast Carcinoma


subject: UMLS:C1541521

object_name: breast carcinoma


subject: UMLS:C1541521

object_name: breast cancer


subject: UMLS:C1541521

object_name: breast neoplasm


subject: UMLS:C1541521

object_name: Early Stage Breast Carcinoma


subject: UMLS:C1541521

object_name: Her2-receptor negative breast cancer


subject: UMLS:C1541521

object_name: HER2 positive breast carcinoma


subject: UMLS:C1541521

object_name: Locally advanced breast cancer


subject: UMLS:C1541521

object_name: triple-negative breast carcinoma


subject: UMLS:C1541521

object_name: hormone receptor negative tumor


subject: UMLS:C1541521

object_name: Hormone receptor positive tumor


subject: UMLS:C1541521

object_name: pediatric angiosarcoma


subject: UMLS:C1541521

object_name: angiosarcoma


subject: UMLS:C1541521

object_name: Adult Angiosarcoma


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UNII:WC1U3R1YMI

subject_name: VEPDEGESTRANT


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UMLS:C5237163

subject_name: ER alpha PROTAC Protein Degrader ARV-471


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: CHEBI:233362

subject_name: Abemaciclib


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UMLS:C4085973


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:TBF1NHY02O

subject_name: AMCENESTRANT


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UNII:TBF1NHY02O


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C4687517


subject: UMLS:C5421014

subject_name: Amcenestrant


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C5421014


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C5706363

subject_name: Polymeric Nanoparticle-conjugated Camptothecin DAN-222


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: UMLS:C5706363


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:80555

subject_name: ENDOXIFEN


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: CHEBI:80555


subject: UNII:HB2U71MNOT

subject_name: ENDOXIFEN, (E)-


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UNII:HB2U71MNOT


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177770

subject_name: Ganetespib


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: PUBCHEM.COMPOUND:9909681

subject_name: lasofoxifene


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: PUBCHEM.COMPOUND:9909681


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: UNII:4HA45S22ZZ


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UNII:K4I4I996O4


subject: UMLS:C4743547

subject_name: Encequidar


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: UMLS:C4743547


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: UMLS:C2981820


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEMBL.COMPOUND:CHEMBL2109406

subject_name: PATRITUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: CHEMBL.COMPOUND:CHEMBL2109406


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UMLS:C3888263


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UMLS:C3896762


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:231087

subject_name: Trilaciclib


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UMLS:C4331494

subject_name: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C4331494


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: UMLS:C0957573


subject: GTOPDB:13627

subject_name: zanidatamab


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: GTOPDB:13627


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UNII:Z20OC92TDI


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: PUBCHEM.COMPOUND:66555030

subject_name: Oliceridine

object_name: Senility


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: disorder of glycogen metabolism


subject: UNII:2P6O7CFW5K

object_name: mitochondrial trifunctional protein deficiency


subject: UNII:2P6O7CFW5K

object_name: acyl-CoA dehydrogenase 9 deficiency


subject: UNII:2P6O7CFW5K

object_name: Carnitine palmitoyltransferase deficiencies (CPT1, CPT2)


subject: UNII:2P6O7CFW5K

object_name: long-chain hydroxyacyl-CoA dehydrogenase deficiency


subject: UNII:2P6O7CFW5K

object_name: pyruvate carboxylase deficiency disease


subject: UNII:2P6O7CFW5K

object_name: Barth syndrome


subject: UMLS:C5201230

subject_name: Paclitaxel Liquid Injection

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3854151

subject_name: Injection, paclitaxel, 1 mg administered


subject: MESH:C538853

object_name: Alzheimer disease type 1


subject: MESH:C538853

object_name: Alzheimer disease


subject: MESH:C039984

subject_name: Bretschneider cardioplegic solution

object_name: congenital heart disease


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:49863420

object_name: Cystic fibrosis pulmonary exacerbation


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: Infection


subject: CHEBI:5551

object_name: infectious disease


subject: CHEBI:5551

object_name: Adverse Event Associated with Infection


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Spinal stenosis of lumbosacral region


subject: CHEBI:231679

subject_name: ipilimumab

object_name: cervical squamous cell carcinoma


subject: CHEBI:231679

object_name: human papilloma virus infection


subject: CHEBI:231679

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:231679

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UNII:4L1AM42NVA

object_name: acquired polycythemia vera


subject: UMLS:C2983773


subject: CHEBI:65326

subject_name: Pictilisib

object_name: Childhood Breast Carcinoma


subject: CHEBI:65326

object_name: breast carcinoma


subject: CHEBI:65326

object_name: breast cancer


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Malignant cachexia


subject: CHEBI:6801

subject_name: Metformin

object_name: Muscle Invasive Bladder Carcinoma


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: concussion


subject: UMLS:C3540792

object_name: Mild Traumatic Brain Injury


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: Hypoxemia


subject: CHEBI:231678

object_name: Hypoxia, CTCAE


subject: CHEBI:231678

object_name: neoplasm


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: stroke disorder


subject: CHEBI:81570

object_name: cerebrovascular disorder


subject: CHEBI:81570

object_name: Stroke (heart beat)


subject: CHEBI:81570

object_name: Stroke, CTCAE


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: GTOPDB:1160

subject_name: hCG


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: CHEBI:59527

object_name: osteoarthritis, hip


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: lumbar spinal stenosis


subject: CHEBI:4636

object_name: spinal stenosis


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:3655

subject_name: Chlorzoxazone

object_name: Drug Interactions


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:6904

subject_name: Metoprolol


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: multiple sclerosis


subject: UNII:0E3D72URPD

object_name: asthma


subject: UNII:79R3ZF226Y

object_name: superficial multifocal basal cell carcinoma


subject: CHEBI:53228


subject: CHEBI:60622


subject: CHEBI:6520

subject_name: Lomustine

object_name: lung cancer


subject: CHEBI:6520

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:2269

object_name: Recurrent lower respiratory tract infections


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: antiphospholipid syndrome


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:8887

subject_name: Rofecoxib


subject: CHEBI:16796

subject_name: Melatonin

object_name: pregnancy preterm


subject: CHEBI:27374

subject_name: Levoinositol

object_name: Androgen excess


subject: CHEBI:6413

subject_name: Letrozole

object_name: Missed abortion


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:131769963

object_name: metastatic gastrointestinal carcinoid tumor


subject: PUBCHEM.COMPOUND:131769963

object_name: PPoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:131769963

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: pancreatic somatostatinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: somatostatinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: recurrent islet cell carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: WDHA Syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: VIPoma


subject: PUBCHEM.COMPOUND:131769963

object_name: glucagonoma


subject: PUBCHEM.COMPOUND:131769963

object_name: insulinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Zollinger-Ellison syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: gastrinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: pancreatic gastrinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UNII:LNU830UGAX

subject_name: AFIMKIBART

object_name: atopic eczema


subject: UMLS:C1831984

subject_name: WT-1 analog peptide vaccine

object_name: leukemia


subject: UMLS:C1831984

object_name: childhood leukemia


subject: UMLS:C1831984

object_name: Myelodysplasia


subject: UMLS:C1831984

object_name: lung cancer


subject: UMLS:C1831984

object_name: lung neoplasm


subject: UMLS:C1831984

object_name: lung carcinoma


subject: UMLS:C1831984

object_name: malignant mesothelioma


subject: UMLS:C1831984

object_name: peritoneum cancer


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: UMLS:C5943288


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Small cell lung cancer recurrent


subject: CHEBI:70839

object_name: Small cell lung cancer limited stage


subject: CHEBI:70839

object_name: Small cell lung cancer extensive stage


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:ZDR4QSJ43F

object_name: head and neck squamous cell carcinoma


subject: UMLS:C0758290

subject_name: IRX 2


subject: CHEBI:49662

subject_name: Indomethacin


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Reactive hypoglycemia


subject: UMLS:C2718754

subject_name: Ilaris


subject: UNII:DY8BBK4G3C

object_name: irritable bowel syndrome


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: atopic eczema/dermatitis (non-specific)


subject: CHEBI:81585

subject_name: cis-11-Methyl-2-dodecenoic acid

object_name: ulcerative colitis


subject: CHEBI:81585

object_name: inflammatory bowel disease 1


subject: UMLS:C3830413

subject_name: DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C3830413

object_name: breast carcinoma


subject: UMLS:C3830413

object_name: breast cancer


subject: UMLS:C3830413

object_name: Carcinoma breast stage IV


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone

object_name: hyperparathyroidism


subject: UNII:N19A0T0E5J

object_name: Hyperparathyroidism, CTCAE


subject: UNII:N19A0T0E5J

object_name: Bone Diseases, Endocrine


subject: PUBCHEM.COMPOUND:193761

subject_name: tetraethylpyrazine

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:193761

object_name: Alzheimer disease


subject: CHEBI:45927

subject_name: Triethyl phosphate


subject: CHEBI:45927


subject: UMLS:C4522161

subject_name: Therapeutic Exchange Plasma


subject: UMLS:C4522161


subject: CHEBI:7466

subject_name: Nandrolone

object_name: Paresis


subject: CHEBI:7466

object_name: Muscle weakness


subject: CHEBI:7466

object_name: end stage renal failure


subject: CHEBI:7466

object_name: Chronic uremia


subject: UMLS:C5961092

subject_name: Anti-B7-H3 Antibody-drug Conjugate DB-1311

object_name: Advanced lung cancer


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002


subject: CHEBI:9566

subject_name: Thioridazine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:9566

object_name: acute myeloid leukemia


subject: UNII:3JWCT8LCME

object_name: hypotension


subject: UNII:3JWCT8LCME

object_name: Hypotension, CTCAE


subject: UNII:7WFB66H4LB


subject: UNII:7WFB66H4LB


subject: DRUGBANK:DB05799


subject: DRUGBANK:DB05799


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Recurrent ovarian cancer


subject: CHEBI:71954

object_name: Recurrent Endometrial Cancer


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: ovarian cancer


subject: MESH:C520255

object_name: ovarian neoplasm


subject: MESH:C520255


subject: MESH:C520255

object_name: endometrial cancer


subject: MESH:C520255

object_name: uterine corpus cancer


subject: MESH:C520255

object_name: endometrial carcinoma


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: adverse effect to anesthesia


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Crohn disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Lidocaine adverse reaction


subject: CHEBI:73604

object_name: Rocuronium adverse reaction


subject: UNII:70FJN2AW22

object_name: childhood neoplasm


subject: UNII:70FJN2AW22

object_name: neoplastic syndrome


subject: UNII:70FJN2AW22

object_name: cancer or benign tumor


subject: UNII:70FJN2AW22

object_name: neoplasm


subject: UMLS:C4287708

subject_name: Androgen Receptor Antagonist SHR3680


subject: UMLS:C4287708


subject: UMLS:C4287708


subject: UMLS:C4287708


subject: UMLS:C5239418

object_name: prostate carcinoma


subject: UMLS:C5239418

object_name: prostate cancer


subject: DRUGBANK:DB14256

subject_name: Centella asiatica

object_name: coronary microvascular disorder


subject: UMLS:C3896835

subject_name: Synthetic hTERT DNA Vaccine INO-1400

object_name: lung cancer


subject: UMLS:C3896835

object_name: lung neoplasm


subject: UMLS:C3896835

object_name: lung carcinoma


subject: UMLS:C3896835

object_name: ovarian cancer


subject: UMLS:C3896835

object_name: ovarian neoplasm


subject: UMLS:C3896835

object_name: ovarian carcinoma


subject: UMLS:C3896835

object_name: Childhood Breast Carcinoma


subject: UMLS:C3896835

object_name: breast carcinoma


subject: UMLS:C3896835

object_name: breast cancer


subject: UMLS:C3896835

object_name: Stomach cancer


subject: UMLS:C3896835

object_name: gastric cancer


subject: UMLS:C3896835

object_name: pancreatic neoplasm


subject: UMLS:C3896835

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3896835

object_name: malignant pancreatic neoplasm


subject: UMLS:C3896835

object_name: Neck Carcinoma


subject: UMLS:C3896835

object_name: head and neck neoplasm


subject: UMLS:C3896835

object_name: head and neck cancer


subject: UMLS:C3896835

object_name: colorectal cancer


subject: UMLS:C3896835

object_name: colorectal carcinoma


subject: UMLS:C3896835

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3896835

object_name: carcinoma of esophagus


subject: UMLS:C3896835

object_name: esophageal cancer


subject: UMLS:C3896835

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3896835

object_name: neoplasm of esophagus


subject: UMLS:C3896835

object_name: liver carcinoma


subject: UMLS:C4722742

subject_name: Synthetic hTERT DNA Vaccine INO-1401

object_name: lung cancer


subject: UMLS:C4722742

object_name: lung neoplasm


subject: UMLS:C4722742

object_name: lung carcinoma


subject: UMLS:C4722742

object_name: ovarian cancer


subject: UMLS:C4722742

object_name: ovarian neoplasm


subject: UMLS:C4722742

object_name: ovarian carcinoma


subject: UMLS:C4722742

object_name: Childhood Breast Carcinoma


subject: UMLS:C4722742

object_name: breast carcinoma


subject: UMLS:C4722742

object_name: breast cancer


subject: UMLS:C4722742

object_name: Stomach cancer


subject: UMLS:C4722742

object_name: gastric cancer


subject: UMLS:C4722742

object_name: pancreatic neoplasm


subject: UMLS:C4722742

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4722742

object_name: malignant pancreatic neoplasm


subject: UMLS:C4722742

object_name: Neck Carcinoma


subject: UMLS:C4722742

object_name: head and neck neoplasm


subject: UMLS:C4722742

object_name: head and neck cancer


subject: UMLS:C4722742

object_name: colorectal cancer


subject: UMLS:C4722742

object_name: colorectal carcinoma


subject: UMLS:C4722742

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4722742

object_name: carcinoma of esophagus


subject: UMLS:C4722742

object_name: esophageal cancer


subject: UMLS:C4722742

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4722742

object_name: neoplasm of esophagus


subject: UMLS:C4722742

object_name: liver carcinoma


subject: UMLS:C3896834

subject_name: Dna plasmid encoding interleukin-12 ino-9012

object_name: lung cancer


subject: UMLS:C3896834

object_name: lung neoplasm


subject: UMLS:C3896834

object_name: lung carcinoma


subject: UMLS:C3896834

object_name: ovarian cancer


subject: UMLS:C3896834

object_name: ovarian neoplasm


subject: UMLS:C3896834

object_name: ovarian carcinoma


subject: UMLS:C3896834

object_name: Childhood Breast Carcinoma


subject: UMLS:C3896834

object_name: breast carcinoma


subject: UMLS:C3896834

object_name: breast cancer


subject: UMLS:C3896834

object_name: Stomach cancer


subject: UMLS:C3896834

object_name: gastric cancer


subject: UMLS:C3896834

object_name: pancreatic neoplasm


subject: UMLS:C3896834

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3896834

object_name: malignant pancreatic neoplasm


subject: UMLS:C3896834

object_name: Neck Carcinoma


subject: UMLS:C3896834

object_name: head and neck neoplasm


subject: UMLS:C3896834

object_name: head and neck cancer


subject: UMLS:C3896834

object_name: colorectal cancer


subject: UMLS:C3896834

object_name: colorectal carcinoma


subject: UMLS:C3896834

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3896834

object_name: carcinoma of esophagus


subject: UMLS:C3896834

object_name: esophageal cancer


subject: UMLS:C3896834

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3896834

object_name: neoplasm of esophagus


subject: UMLS:C3896834

object_name: liver carcinoma


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Bowen's Disease


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: monoclonal gammopathy of uncertain significance


subject: CHEBI:91397

object_name: monoclonal B-cell lymphocytosis


subject: CHEBI:91397

object_name: Malignant Solid Neoplasm


subject: CHEBI:91397

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:91397

object_name: aplastic anemia


subject: CHEBI:91397

object_name: idiopathic aplastic anemia


subject: PR:000011592

object_name: hypertension


subject: PR:000011592

object_name: Hypertension, CTCAE


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: childhood malignant neoplasm


subject: CHEBI:94518

object_name: acquired; coagulation defect


subject: CHEBI:94518

object_name: blood coagulation disease


subject: CHEBI:94518

object_name: vascular hemostatic disease


subject: UNII:P7186074QC

subject_name: Rozanolixizumab

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C4085992

subject_name: Antimetabolite FF-10502

object_name: Solid Neoplasm


subject: UMLS:C4085992

object_name: lymphoma


subject: CHEBI:6801

subject_name: Metformin

object_name: classic familial adenomatous polyposis


subject: CHEBI:6801

object_name: Adenomatous colonic polyposis


subject: CHEBI:3441

subject_name: Carvedilol

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: ovarian carcinoma


subject: UNII:322ZMR6920

object_name: allergic asthma


subject: CHEBI:5100

subject_name: Flucytosine

object_name: Recurrent Malignant Glioma


subject: CHEBI:5100

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEBI:5100

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:5100

object_name: Adult Mixed Glioma


subject: CHEBI:5100

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:5100

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:5100

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:5100

object_name: Adult Gliosarcoma


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]


subject: UMLS:C5575704


subject: UMLS:C5575704

object_name: brain cancer


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: CHEBI:6427

subject_name: Leuprolide

object_name: male infertility


subject: CHEBI:6427

object_name: female infertility


subject: UMLS:C4547381

object_name: Mycoses


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Poisoning by methadone


subject: PUBCHEM.COMPOUND:9848990

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:9848990

object_name: Inflammation


subject: CHEBI:7459

subject_name: Naloxone


subject: CHEBI:7459


subject: CHEBI:7459


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: UNII:Q0656F336Y

object_name: Non-cystic fibrosis bronchiectasis


subject: UNII:Q0656F336Y

object_name: cystic fibrosis


subject: CHEBI:27375

subject_name: Vinblastine

object_name: diffuse large B-cell lymphoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: glioblastoma


subject: UNII:PQX0D8J21J

object_name: Childhood Glioblastoma


subject: UNII:PQX0D8J21J

object_name: adult glioblastoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:50858

subject_name: corticosteroid

object_name: IgA Nephropathy


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: DRUGBANK:DB17070

object_name: Parkinson disease


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:35482

subject_name: opioid analgesic

object_name: Pain, Intractable


subject: CHEBI:35482

object_name: Low back pain


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Urinary Urgency


subject: CHEBI:63611

object_name: endometriosis


subject: CHEBI:63611

object_name: Cough


subject: CHEBI:63611

object_name: Cough, CTCAE


subject: CHEBI:229657

subject_name: Lotilaner

object_name: Posterior blepharitis


subject: CHEBI:229657

object_name: Demodex folliculitis


subject: UMLS:C0005515

subject_name: Biological Factors

object_name: carcinoid tumor


subject: UMLS:C0005515

object_name: neuroendocrine neoplasm


subject: CHEBI:6888

object_name: frozen shoulder


subject: CHEBI:6888

object_name: bursitis


subject: GTOPDB:13086

subject_name: efanesoctocog alfa

object_name: severe hemophilia A


subject: UNII:WH7BHQ0RB4

subject_name: EFANESOCTOCOG ALFA


subject: UMLS:C5421030


subject: UMLS:C2366367

subject_name: Cinryze

object_name: end stage renal failure


subject: UMLS:C2366367

object_name: Chronic uremia


subject: UMLS:C2366367

object_name: chronic kidney disease


subject: UNII:JUP57A8EPZ

object_name: Advanced breast cancer


subject: DRUGBANK:DB19218

subject_name: Camizestrant


subject: PUBCHEM.COMPOUND:155586901


subject: DRUGBANK:DB18982

subject_name: Saruparib


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: Irritable heart


subject: CHEBI:55352

object_name: neurocirculatory asthenia


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:2904


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: CHEBI:5931

subject_name: insulin human

object_name: Cystic fibrosis related diabetes


subject: UMLS:C0876064

subject_name: Lantus


subject: CHEBI:31355

subject_name: Carboplatin

object_name: primary central nervous system lymphoma


subject: CHEBI:16899

subject_name: Mannitol


subject: CHEBI:32150


subject: CHEBI:132112


subject: UMLS:C1721378

subject_name: Galvus

object_name: type 2 diabetes mellitus


subject: UNII:RPC6R41K4I

subject_name: Brostallicin

object_name: malignant soft tissue neoplasm


subject: UNII:RPC6R41K4I

object_name: sarcoma


subject: UNII:RPC6R41K4I

object_name: Plexosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Childhood Neuroblastoma


subject: CHEBI:52717

object_name: neuroblastoma


subject: UMLS:C3886640

object_name: chronic myelomonocytic leukemia


subject: UMLS:C3886640

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:53477739

object_name: Physical trauma


subject: PUBCHEM.COMPOUND:53477739

object_name: Trauma


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5204434

subject_name: RET Inhibitor

object_name: thyroid tumor


subject: UMLS:C5204434

object_name: thyroid gland carcinoma


subject: UMLS:C5204434

object_name: thyroid cancer


subject: CHEBI:3699

subject_name: Cimetidine

object_name: Post-herpetic neuritis


subject: PUBCHEM.COMPOUND:131704328

subject_name: Alginic acid

object_name: Overweight


subject: PUBCHEM.COMPOUND:131704328

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:131704328

object_name: obesity


subject: PUBCHEM.COMPOUND:131704328

object_name: Obesity, CTCAE


subject: CHEBI:58187

subject_name: alginate


subject: CHEBI:58187


subject: CHEBI:58187


subject: CHEBI:58187


subject: UMLS:C0102137


subject: UMLS:C0102137


subject: UMLS:C0102137


subject: UMLS:C0102137


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Solid Neoplasm


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Weight Gain


subject: CHEBI:31236

object_name: Weight Gain, CTCAE


subject: CHEBI:31236

object_name: Adverse drug response


subject: CHEBI:31236

object_name: Has shown side effects from medication


subject: UMLS:C4733246

subject_name: Gasmotin

object_name: gastritis


subject: UMLS:C4733246

object_name: Gastritis, CTCAE


subject: UMLS:C2830141

object_name: head and neck neoplasm


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: cystic fibrosis


subject: CHEBI:72544

subject_name: flavonoids

object_name: colorectal cancer


subject: CHEBI:72544

object_name: colorectal carcinoma


subject: CHEBI:72544

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:47916

subject_name: flavonoid


subject: CHEBI:47916


subject: CHEBI:47916


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: UMLS:C5392440

object_name: c.surgical procedure; cardiac


subject: UMLS:C5392440

object_name: systemic inflammatory response syndrome


subject: UMLS:C5392705

subject_name: vilobelimab


subject: UMLS:C5392705


subject: GTOPDB:11346


subject: GTOPDB:11346


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: Tourette syndrome


subject: CHEBI:133017

object_name: tardive dyskinesia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Androgen excess


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: digestive system neoplasm


subject: UNII:5S371K6132

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:5S371K6132

object_name: gastric neoplasm


subject: UNII:5S371K6132

object_name: stomach disease


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C4763517

object_name: Myelodysplasia


subject: UMLS:C4763517

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C4763517

object_name: myoclonic dystonia 11


subject: UMLS:C0592060

subject_name: Rifinah

object_name: HIV infection


subject: PUBCHEM.COMPOUND:86278323

subject_name: Pegnivacogin

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:86278323

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL2107870

subject_name: PEGNIVACOGIN


subject: CHEMBL.COMPOUND:CHEMBL2107870


subject: DRUGBANK:DB16089

subject_name: Anivamersen


subject: DRUGBANK:DB16089


subject: CHEBI:233291

subject_name: Saredutant

object_name: anxiety


subject: CHEBI:233291

object_name: anxiety disorder


subject: CHEBI:233291

object_name: Anxiety symptoms


subject: CHEBI:233291

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:233291

object_name: Anxiety, CTCAE 5.0


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: testicular germ cell tumor 1


subject: UNII:M487QF2F4V

object_name: testicular germ cell tumor


subject: UNII:M487QF2F4V

object_name: childhood testicular germ cell tumor


subject: UNII:M487QF2F4V

object_name: extragonadal germ cell tumor


subject: UNII:M487QF2F4V

object_name: cancer of unknown primary site


subject: UNII:M487QF2F4V

object_name: bladder tumor


subject: UNII:M487QF2F4V

object_name: urinary bladder carcinoma


subject: UNII:M487QF2F4V

object_name: urinary bladder cancer


subject: UNII:M487QF2F4V

object_name: childhood bladder carcinoma


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603

object_name: renal carcinoma


subject: UMLS:C1321603

object_name: kidney neoplasm


subject: UMLS:C1321603

object_name: kidney cancer


subject: UMLS:C1321603

object_name: malignant soft tissue neoplasm


subject: UMLS:C1321603

object_name: sarcoma


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:4911

subject_name: Etoposide

object_name: Neck Carcinoma


subject: CHEBI:4911

object_name: head and neck neoplasm


subject: CHEBI:4911

object_name: head and neck cancer


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864

object_name: lung cancer


subject: CHEBI:5864

object_name: lung neoplasm


subject: CHEBI:5864

object_name: lung carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: cancer of unknown primary site


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:31355

subject_name: Carboplatin

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:26195

subject_name: polyphenol

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: hepatitis C virus, susceptibility to


subject: PUBCHEM.COMPOUND:76668718

subject_name: Pibrentasvir


subject: PUBCHEM.COMPOUND:14586216

subject_name: Prunus inhibitor b


subject: CHEBI:53725

subject_name: poly(isobutylene)


subject: PUBCHEM.COMPOUND:2269

object_name: Dental implant failed


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:151315

subject_name: Heparin

object_name: Community-Acquired Pneumonia


subject: KEGG.COMPOUND:C00374


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Multiple Trauma


subject: CHEBI:6121

subject_name: Ketamine


subject: RXCUI:1999667

subject_name: bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet

object_name: HIV-1 infection


subject: UMLS:C0752700

object_name: breast disorder


subject: UMLS:C0752700

object_name: breast neoplasm


subject: UMLS:C0752700

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Libido, CTCAE


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: ovarian hyperstimulation syndrome


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: mantle cell lymphoma


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:114785

subject_name: Erlotinib

object_name: malignant epithelioid mesothelioma


subject: CHEBI:114785

object_name: sarcomatoid mesothelioma


subject: CHEBI:76018

subject_name: Riociguat

object_name: cystic fibrosis


subject: UMLS:C2717562


subject: CHEBI:52763

object_name: premature ejaculation


subject: HMDB:HMDB0032337

subject_name: Hydroxypropyl cellulose

object_name: Myelodysplasia


subject: MESH:C482584

subject_name: Seasonale

object_name: Osteopenia


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:9144

subject_name: Silibinin

object_name: liver disorder


subject: CHEBI:9144


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: UMLS:C0935952

subject_name: Oncophage

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C0935952

object_name: Recurrent Glioblastoma


subject: UMLS:C0935952

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C0935952

object_name: Adult Gliosarcoma


subject: UMLS:C0935952

object_name: gliosarcoma


subject: UMLS:C0935952

object_name: Childhood Gliosarcoma


subject: UMLS:C0305578

subject_name: Centrum

object_name: cataract


subject: UMLS:C0305578

object_name: Cataract, CTCAE 3.0


subject: UMLS:C0305578

object_name: Cataract, CTCAE 5.0


subject: UMLS:C0305578

object_name: cataract on exam (physical finding)


subject: CHEBI:5098

subject_name: Flucloxacillin

object_name: Drug Interactions


subject: UMLS:C5882232

object_name: dilated cardiomyopathy 1B


subject: PUBCHEM.COMPOUND:75038


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: UNII:42T48Q7A6O

object_name: liver carcinoma


subject: UMLS:C4745020


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: sarcoma


subject: PUBCHEM.COMPOUND:135423438

object_name: soft tissue sarcoma


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: B-cell neoplasm


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:15843

subject_name: Arachidonate

object_name: schistosomiasis


subject: CHEBI:22599

subject_name: arabinose


subject: PR:000003562

subject_name: ATP-binding cassette sub-family C member 6


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Malaria, antepartum


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:3685

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3685

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3685

object_name: Philadelphia chromosome, Ph^1^, absent


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:4613T5ZY7G

subject_name: inosine dialdehyde


subject: UNII:4613T5ZY7G


subject: UNII:4613T5ZY7G


subject: CHEBI:24786

subject_name: iminodiacetic acid


subject: CHEBI:24786


subject: CHEBI:24786


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: Recurrent ovarian cancer


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: CHEBI:8871

subject_name: Risperidone

object_name: velocardiofacial syndrome


subject: CHEBI:8871

object_name: DiGeorge syndrome


subject: CHEBI:8871

object_name: 22q11.2 deletion syndrome


subject: UNII:LPU25F15UQ

subject_name: Azeliragon

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: pregnancy disorder


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: pervasive developmental disorder


subject: CHEBI:50275

object_name: autism


subject: CHEBI:50275

object_name: autism spectrum disorder


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UMLS:C2353620

object_name: Parkinson disease


subject: UMLS:C2353619


subject: PUBCHEM.COMPOUND:130310079

object_name: narcolepsy


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: cocaine abuse


subject: GTOPDB:2509

subject_name: NO

object_name: pulmonary embolism


subject: CHEBI:33396

subject_name: nobelium


subject: RXCUI:1375946

subject_name: doxylamine / pyridoxine Delayed Release Oral Tablet

object_name: Morning nausea


subject: UNII:49K58SMZ7U

subject_name: BETAHISTINE HYDROCHLORIDE

object_name: Overweight


subject: UNII:49K58SMZ7U

object_name: overnutrition


subject: UNII:49K58SMZ7U

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:49K58SMZ7U

object_name: obesity


subject: UNII:49K58SMZ7U

object_name: Obesity, CTCAE


subject: CHEBI:35677

subject_name: Betahistine


subject: CHEBI:35677


subject: UMLS:C0962969

subject_name: RAD 001

object_name: Osteosarcoma


subject: UMLS:C0962969

object_name: bone sarcoma


subject: UMLS:C0962969

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: GTOPDB:13796

subject_name: serplulimab

object_name: HER2-positive gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C1138626

subject_name: cocoa extract

object_name: Fall, CTCAE


subject: UMLS:C1138626

object_name: Falls


subject: UMLS:C1138626

object_name: Bone fracture


subject: UMLS:C1138626

object_name: Fracture, CTCAE


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: DRUGBANK:DB10977


subject: DRUGBANK:DB10977


subject: DRUGBANK:DB10977


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UNII:2372V1TKXK

subject_name: Lanadelumab

object_name: hypotension of hemodialysis


subject: UNII:2372V1TKXK

object_name: Complication of hemodialysis


subject: UNII:6802Q86R7I

object_name: Alzheimer disease


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Sepsis


subject: CHEBI:6015

object_name: Sepsis, CTCAE


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:25805

subject_name: oxygen atom


subject: CHEBI:25805


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UMLS:C3831455

object_name: adrenogenital syndrome


subject: UMLS:C3831455

object_name: congenital adrenal hyperplasia


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: prostate cancer


subject: CHEBI:94366

subject_name: itraconazole

object_name: blastomycosis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: neoplasm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: DRUGBANK:DB06375

object_name: Atrophy of alveolar ridges


subject: CHEBI:232469

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:94463

object_name: Carcinoma breast stage IV


subject: CHEBI:63580

subject_name: Ribavirin


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: hepatitis C


subject: UNII:B72HH48FLU

object_name: chronic granulomatous disease


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: gallbladder cancer


subject: UNII:M89N0Q7EQR

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: gallbladder carcinoma


subject: UNII:M89N0Q7EQR

object_name: carcinoma of esophagus


subject: UNII:M89N0Q7EQR

object_name: esophageal cancer


subject: UNII:M89N0Q7EQR

object_name: Childhood Esophageal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: neoplasm of esophagus


subject: UNII:M89N0Q7EQR

object_name: liver cancer


subject: UNII:M89N0Q7EQR

object_name: liver neoplasm


subject: UNII:M89N0Q7EQR

object_name: Adult Liver Carcinoma


subject: UNII:M89N0Q7EQR

object_name: liver carcinoma


subject: UNII:M89N0Q7EQR

object_name: intestinal cancer


subject: CHEBI:91327

subject_name: Tivozanib


subject: UMLS:C1327815

subject_name: Oncolytic Newcastle Disease Virus Strain PV701

object_name: cancer


subject: UMLS:C1327815

object_name: neoplasm


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: arteriosclerosis disorder


subject: CHEBI:46245

object_name: atherosclerosis


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: head and neck neoplasm


subject: UMLS:C4520835

subject_name: Factor viii (antihemophilic factor, human) per i.u.

object_name: von Willebrand disease (hereditary or acquired)


subject: UMLS:C0700346

subject_name: Koate-DVI


subject: UMLS:C4718976

subject_name: Beroctocog alfa


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: Invasive fungal infection


subject: UMLS:C0532508


subject: UMLS:C2267057

subject_name: Recombinant Activated Protein C [EPC]

object_name: septic shock


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: pancreatic neuroendocrine neoplasm


subject: UMLS:C3826869

subject_name: SOM230 LAR


subject: UMLS:C3826869

object_name: pancreatic neuroendocrine tumor


subject: PUBCHEM.COMPOUND:167993668

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C2351370


subject: CHEBI:7789

subject_name: Orphenadrine

object_name: Muscle spasm


subject: CHEBI:7789

object_name: Hyperkinesia


subject: PUBCHEM.COMPOUND:3081907

subject_name: Motexafin lutetium

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Cervical intraepithelial neoplasia grade 2


subject: PUBCHEM.COMPOUND:3081907

object_name: uterine cervix carcinoma in situ


subject: UNII:0V38NF6N89


subject: UNII:0V38NF6N89


subject: UNII:0V38NF6N89


subject: UNII:0V38NF6N89


subject: UNII:1D2T74921W

subject_name: NAFAMOSTAT MESYLATE

object_name: Hemorrhage


subject: UNII:1D2T74921W

object_name: Complication of dialysis


subject: PUBCHEM.COMPOUND:9868041


subject: PUBCHEM.COMPOUND:9868041


subject: CHEBI:135466

subject_name: Nafamostat


subject: CHEBI:135466


subject: UMLS:C0207682

subject_name: nafamostat mesilate


subject: UMLS:C0207682


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Stage IIB Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:47898

object_name: Stage IV Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:47898

object_name: Stage III Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:47898

object_name: childhood pleomorphic rhabdomyosarcoma


subject: CHEBI:47898

object_name: pleomorphic rhabdomyosarcoma


subject: CHEBI:47898

object_name: adult pleomorphic rhabdomyosarcoma


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C4744993

object_name: lung cancer


subject: UMLS:C4744993

object_name: lung neoplasm


subject: UMLS:C4744993

object_name: lung carcinoma


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:67271

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:67271

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:67271

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:67271

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:67271

object_name: pancreatic adenocarcinoma


subject: CHEBI:95060

subject_name: Dinaciclib


subject: CHEBI:95060


subject: CHEBI:95060


subject: CHEBI:95060


subject: CHEBI:95060


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Neonatal seizure


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: Recurrence


subject: UNII:G8RGG88B68

object_name: Recurrent Malignant Neoplasm


subject: UNII:G8RGG88B68

object_name: Recurrent disease


subject: UNII:G8RGG88B68

object_name: Recurrent tumor


subject: UNII:G8RGG88B68

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:91951

object_name: McCune-Albright syndrome


subject: CHEBI:91951

object_name: precocious puberty


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: cancer


subject: CHEBI:3215

object_name: neoplasm


subject: CHEBI:8774

subject_name: Ramipril

object_name: Complication of hemodialysis


subject: CHEBI:8774

object_name: End stage renal failure on dialysis


subject: CHEBI:9927

subject_name: Valsartan


subject: UMLS:C5447491

subject_name: CERAN OP-1250

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5447491

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C4053581

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEBI:46081

subject_name: Fluconazole


subject: UMLS:C4317170

object_name: anemia


subject: UMLS:C4317170

object_name: Anemia, CTCAE


subject: UNII:0P49L952WZ

subject_name: Andrographis paniculata extract

object_name: osteoarthritis, knee


subject: UMLS:C5203466

subject_name: Zoledronic Acid Liquid Injection

object_name: postmenopausal osteoporosis


subject: CHEBI:60791

subject_name: Xylocard

object_name: temporomandibular joint dysfunction syndrome


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:8871

subject_name: Risperidone

object_name: post-traumatic stress disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: dental caries


subject: DRUGBANK:DB19282

object_name: Dental Caries, CTCAE


subject: MESH:C557525

subject_name: SB939 compound

object_name: leukemia


subject: MESH:C557525

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:56603532

subject_name: Pracinostat


subject: PUBCHEM.COMPOUND:56603532


subject: UMLS:C4722693

subject_name: Risperidone Lipid Formulation VAL401

object_name: esophageal adenocarcinoma


subject: UMLS:C4722693

object_name: lung adenocarcinoma


subject: UMLS:C4722693

object_name: cervical adenocarcinoma


subject: UMLS:C4722693

object_name: adenocarcinoma


subject: UMLS:C4722693

object_name: bile duct adenocarcinoma


subject: UMLS:C4722693

object_name: gastric adenocarcinoma


subject: UMLS:C4722693

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: septic shock


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: Subfertility


subject: UMLS:C0078129


subject: CHEBI:6456

object_name: ovarian cyst


subject: CHEBI:6456

object_name: appendicitis


subject: CHEBI:6456

object_name: Appendicitis, CTCAE


subject: UMLS:C5691206

object_name: Parkinson disease


subject: UMLS:C5417947

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Adult Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:70789204

object_name: rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:23995

subject_name: N-ethyl-N-nitrosourea

object_name: breast neoplasm


subject: CHEBI:49018

subject_name: neuraminic acid


subject: PR:000011149

subject_name: E3 ubiquitin-protein ligase NEURL1


subject: PR:000011145


subject: UniProtKB:P06494

subject_name: ERBB2_RAT Receptor tyrosine-protein kinase erbB-2 (sprot)


subject: CHEBI:229496

subject_name: N-omega-carboxyethyl-L-arginine


subject: PR:000001330

subject_name: cell adhesion molecule CEACAM5


subject: UMLS:C0007082

subject_name: Carcinoembryonic Antigen


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic Esophageal Squamous Cell Carcinoma


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: stroke disorder


subject: CHEBI:29007

object_name: cerebrovascular disorder


subject: CHEBI:29007

object_name: Stroke (heart beat)


subject: CHEBI:29007

object_name: Stroke, CTCAE


subject: CHEBI:29007

object_name: Ischemic stroke


subject: CHEBI:29007

object_name: nervous system disorder


subject: CHEBI:29007

object_name: CNS disorder


subject: CHEBI:29007

object_name: brain disorder


subject: CHEBI:29007

object_name: cardiovascular disorder


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:84040

object_name: infertility


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:231679

subject_name: ipilimumab

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4688492

object_name: Machado-Joseph disease


subject: UMLS:C4688492

object_name: spinocerebellar ataxia type 6


subject: UMLS:C4688492

object_name: spinocerebellar ataxia type 2


subject: UMLS:C4688492

object_name: spinocerebellar ataxia type 1


subject: UMLS:C4688492

object_name: multiple system atrophy, cerebellar type


subject: UMLS:C1613030

subject_name: Mycamine

object_name: disseminated candidiasis


subject: UMLS:C1613030

object_name: candidiasis, invasive


subject: UMLS:C1613030

object_name: esophageal candidiasis


subject: UMLS:C1613030

object_name: Oropharyngeal candidiasis


subject: UMLS:C1613030

object_name: candidemia


subject: UMLS:C1456762

object_name: superficial multifocal basal cell carcinoma


subject: CHEBI:201443


subject: UNII:7686S50JAH

subject_name: ingenol mebutate


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: pulmonary sarcoidosis


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Pregnant


subject: CHEBI:8107

object_name: Maternal-Fetal Infection Transmission


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: acute promyelocytic leukemia


subject: CHEBI:135918

object_name: atrichia with papular lesions


subject: CHEBI:133021

subject_name: Venetoclax


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: peritoneum cancer


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA

object_name: fallopian tube carcinoma


subject: UNII:P050J5FWC5

object_name: fallopian tube cancer


subject: UNII:P050J5FWC5

object_name: ovarian cancer


subject: UNII:P050J5FWC5

object_name: ovarian neoplasm


subject: UNII:P050J5FWC5

object_name: ovarian carcinoma